Alpine Woods Capital Investors’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,000
Closed -$1.59M 215
2021
Q4
$1.59M Hold
3,000
0.16% 131
2021
Q3
$1.4M Hold
3,000
0.15% 136
2021
Q2
$1.42M Hold
3,000
0.15% 138
2021
Q1
$1.38M Hold
3,000
0.15% 141
2020
Q4
$1.6M Hold
3,000
0.19% 127
2020
Q3
$1.44M Hold
3,000
0.22% 128
2020
Q2
$1.35M Hold
3,000
0.26% 106
2020
Q1
$1.3M Hold
3,000
0.29% 91
2019
Q4
$1.32M Hold
3,000
0.25% 92
2019
Q3
$1.25M Hold
3,000
0.23% 91
2019
Q2
$1.08M Hold
3,000
0.22% 106
2019
Q1
$960K Buy
+3,000
New +$921K 0.21% 113
2014
Q1
Sell
-12,000
Closed -$919K 445
2013
Q4
$919K Hold
12,000
0.05% 213
2013
Q3
$858K Hold
12,000
0.05% 210
2013
Q2
$869K Buy
+12,000
New +$880K 0.06% 199

Other funds holding CHE

Alpine Woods Capital Investors's CHE Position: Q1 2022 in Review

Alpine Woods Capital Investors sold out of Chemed (CHE) in Q1 2022, closing a stake of 3,000 shares — an estimated $1.59M sold.

Alpine Woods Capital Investors first reported a position in CHE in Q2 2013 and held it in 15 quarters. The position peaked at $1.6M in Q4 2020. 426 funds tracked by Wall St. Rank hold CHE as of Q1 2022.

  • Alpine Woods Capital Investors reported no remaining Chemed position as of Q1 2022 after selling out during the quarter.
  • Alpine Woods Capital Investors sold 3,000 Chemed shares in Q1 2022, an estimated $1.59M.
  • Alpine Woods Capital Investors first reported a position in Chemed in Q2 2013 and held it in 15 quarters.
  • Alpine Woods Capital Investors's Chemed position peaked at $1.6M in Q4 2020.
  • 426 funds tracked by Wall St. Rank held Chemed as of Q1 2022.

Based on Alpine Woods Capital Investors's 13F filing for Q1 2022, filed 10 May 2022.